Tilray Brands (TLRY) Revenue (2017 - 2026)
Tilray Brands (TLRY) posted Revenue of $206.7 million for Q1 2026, down 4.95% on a QoQ basis from $217.5 million in Q4 2025, and up 11.28% year-over-year from $185.8 million in Q1 2025.
Tilray Brands (TLRY) Revenue (2017 - 2026) Analysis & Trends
Tilray Brands' Revenue history runs 10 years deep, the most recent figure standing at $206.7 million for Q1 2026.
- Quarterly Revenue rose 11.28% year-over-year to $206.7 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $858.3 million (up 3.82% YoY) and the FY2025 annual result came in at $821.3 million, up 4.1% from the prior year.
- Revenue was $206.7 million for Q1 2026 at Tilray Brands, down from $217.5 million in the prior quarter.
- Across five years, Revenue topped out at $229.9 million in Q2 2024 and bottomed at $144.1 million in Q4 2022.
- A 5-year average of $186.8 million and a median of $188.3 million in 2024 frame the typical range for Revenue.
- Annual changes were most pronounced in 2022 — Revenue fell 8.82% — and 2023, when it surged 34.44%.
- Tilray Brands' Revenue stood at $144.1 million in 2022, then jumped by 34.44% to $193.8 million in 2023, then advanced by 8.87% to $211.0 million in 2024, then advanced by 3.11% to $217.5 million in 2025, then dropped by 4.95% to $206.7 million in 2026.
- Business Quant data shows TLRY's Revenue at $206.7 million in Q1 2026, $217.5 million in Q4 2025, and $209.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 3.98 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 2.26 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 6.98 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 781.50 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 3.51 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 814.50 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 1.37 Bn |
| 10 | Tilray Brands | 439.44 Mn | 379.24 Mn | 54.95 Mn | 206.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 206.73 Mn |
| Nov 30, 2025 | 217.51 Mn |
| Aug 31, 2025 | 209.50 Mn |
| May 31, 2025 | 224.54 Mn |
| Feb 28, 2025 | 185.78 Mn |
| Nov 30, 2024 | 210.95 Mn |
| Aug 31, 2024 | 200.04 Mn |
| May 31, 2024 | 229.88 Mn |
| Feb 29, 2024 | 188.34 Mn |
| Nov 30, 2023 | 193.77 Mn |
| Aug 31, 2023 | 176.95 Mn |
| May 31, 2023 | 184.19 Mn |
| Feb 28, 2023 | 145.59 Mn |
| Nov 30, 2022 | 144.14 Mn |
| Aug 31, 2022 | 153.21 Mn |
| May 31, 2022 | 153.33 Mn |
| Feb 28, 2022 | 151.87 Mn |
| Nov 30, 2021 | 155.15 Mn |
| Aug 31, 2021 | 168.02 Mn |
| May 31, 2021 | 142.24 Mn |